Cancer’s future may lie in combination therapy—pairing treatments to outsmart tumors, boost survival, and bring new hope ...

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

Researchers found that adding a third immune-targeting drug to existing therapies helped shrink tumors in lab models of ...

Silymarin, vitamin E, and phospholipids combination therapy effectively reduces liver steatosis, fibrosis, and metabolic risk ...

By 2008, additional RCTs utilizing combination therapy had been conducted (Table 4). 22,32,37-52 PACES was the first PAH combination therapy study of significant size (N = 267).

WASHINGTON — Only 8% of patients with pulmonary arterial hypertension initiating combination therapy were given both medications on the same day, according to research presented at the American ...

Treating psoriatic arthritis (PsA) patients with more than one targeted therapy appears to be just fine, with no increased ...

Review Published: 23 February 2017 Triple-combination therapy in the treatment of hypertension: a review of the evidence R Düsing, B Waeber, M Destro, C Santos Maia & P Brunel Journal of Human ...

Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

Original Article Published: 02 April 2015 Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension O Petrák, T Zelinka ...

In this video from the American Society of Retina Specialists annual meeting, Charles C. Wykoff, MD, PhD, FASRS, discusses ...